# Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix

> **NCT00084890** · PHASE1 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 15 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00084890
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-11
- **Primary completion:** 2007-03
- **Final completion:** 2010-04
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2018-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00084890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00084890, "Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00084890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*